LIGHT-CHAIN RATIO OF SERUM IGA1 IN IGA NEPHROPATHY
Publication in refereed journal


Times Cited
Web of Science12WOS source URL (as at 01/12/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractPatients with primary IgA nephropathy have deposits of IgA1 in their kidneys and increased IgA1 in circulation. We had previously shown that IgA nephritic patients displayed a unique immunological response characterized by a predominance of IgA with lambda chain in glomerular deposits and in circulation. We have now studied the kappa/lambda (k/lambda) ratio of serum IgA1 in 21 IgA nephritic patients at quiescence, with 11 patients investigated during exacerbation as well. A novel enzyme-linked immunosorbent assay was used with monoclonal mouse anti-human IgA1 as the solid-phase capture antibody and peroxidase-labeled anti-human kappa and lambda antibodies as tracers. The ratio of serum IgA1 to total IgA (mean +/- SD) was significantly higher in patients (90.1 +/- 8.2% at quiescence, P < 0.01; 88.7 +/- 8.1% during exacerbation, P < 0.02) than in 20 healthy age- and sex-matched controls (80.0 +/- 9.8%). Furthermore, serum IgA1 kappa/lambda ratios were significantly lower in patients (1.02 +/- 0.27 at quiescence, P < 0.01; 0.93 +/- 0.16 during exacerbation, P < 0.01) than in controls (1.31 +/- 0.30). These findings indicate a predominance of lambda light-chain IgA1 in the serum of IgA nephritic patients. However, no difference in IgA1 kappa/lambda ratio was observed in these patients at quiescence and during exacerbation.
All Author(s) ListCHUI SH, LAM CWK, LEWIS WHP, LAI KN
Journal nameJournal of Clinical Immunology
Year1991
Month7
Day1
Volume Number11
Issue Number4
PublisherPLENUM PUBL CORP
Pages219 - 223
ISSN0271-9142
LanguagesEnglish-United Kingdom
KeywordsENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA); IGA NEPHROPATHY; IGA1; KAPPA-LAMBDA RATIO
Web of Science Subject CategoriesImmunology; IMMUNOLOGY

Last updated on 2020-01-12 at 23:51